Skip to content

Former FDA-OCE Director Richard Pazdur: ‘there is a palpable sense of anxiety at FDA’
Clinical care still needs human intelligence in the AI era
OPN-6602 in MM granted FDA Fast Track Designation
SOHO strengthens global leadership in blood cancer research
SOHO President Dr. John F. DiPersio honored with top AACR award

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Saad Usmani, MD

Cellular Therapy

Saad Usmani, MD

Leukemia

Saad Usmani, MD

Lymphoma

Saad Usmani, MD

Multiple Myeloma

Saad Usmani, MD

Myelodysplastic Syndromes

Saad Usmani, MD

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

April 18, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Saad Usmani, MD

Saad Usmani, MD

by sohonews
January 31, 2025
0 Comments
Less than a minute
662 Views
1 year ago

Share This Post:

Facebook Twitter Pinterest Whatsapp Cloud StumbleUpon Print Share via Email

Related Post

Richard Pazdur_AACR_800x600

AACR 2026, Cellular Therapy, Leukemia, Lymphoma, Meetings / Conferences, Multiple Myeloma, Myelodysplastic Syndromes, News

Former FDA-OCE Director Richard Pazdur: ‘there is a palpable

April 17, 2026

Shyr second shot

Cellular Therapy, Leukemia, Lymphoma, Meetings / Conferences, News

Clinical care still needs human intelligence in the AI

April 16, 2026

FDA laptop

Multiple Myeloma

OPN-6602 in MM granted FDA Fast Track Designation

April 15, 2026

Janet_800x600

Ambassador Program, News, Society Updates

SOHO strengthens global leadership in blood cancer research

April 14, 2026

800*600

AACR 2026, Trending now, Acute Lymphoblastic Leukemia, Multiple Myeloma

SOHO President Dr. John F. DiPersio honored with top

April 13, 2026

Exclusive session

SOHO 2026, Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndromes, News, Society Updates

SOHO announces exclusive MDS, AML session on September 8

April 10, 2026

Top Categories

Cellular Therapy

67

Leukemia

104

Lymphoma

113

Multiple Myeloma

90

Myelodysplastic Syndromes

35

Myeloproliferative Neoplasms

21

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Saad Usmani, MD

Cellular Therapy

Saad Usmani, MD

Leukemia

Saad Usmani, MD

Lymphoma

Saad Usmani, MD

Multiple Myeloma

Saad Usmani, MD

Myelodysplastic Syndromes

Saad Usmani, MD

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Richard Pazdur_AACR_800x600

Former FDA-OCE Director Richard Pazdur: ‘there is a palpable sense of anxiety at FDA’

Shyr second shot

Clinical care still needs human intelligence in the AI era

FDA laptop

OPN-6602 in MM granted FDA Fast Track Designation

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.